Philip J. Wyatt Wins 2024 Pittcon Heritage Award
Philip J. Wyatt, the founder of Wyatt Technology was presented with the Heritage Award on February 25 at Pittcon in San Diego, California. This yearly award honors the work of entrepreneurs that have shaped the instrument and laboratory supplies industry. Previous winners include Masao Horiba, the founder of Horiba, and Kathryn Hatch-Darrow, the founder of Hatch Chemical Company.
Wyatt received his Ph.D. from Florida State University in 1959 and began his career in the aeronautic division of the Ford Motor Company. In 1967, he launched Science Spectrum and developed instruments to study inverse scattering.
Wyatt launched Wyatt Technology in 1983 with a multi-angle light scattering (MALS) detector. Today, the company develops instruments for companies in the biotech, pharmaceutical, polymer, academic, and government industries. Wyatt Technology was sold to Waters for $1.4 billion in 2023.
In addition to his work at the company, Wyatt is the author of more than 70 publications, has contributed to 11 books, and holds more than 30 domestic patents related to laser light scattering and other technologies. He also has more than 60 derived foreign patents and new filings.
PFAS Analysis in Practice: A RAFA 2024 Interview with Stefan van Leuwen
January 10th 2025At the Recent Advances in Food Analysis (RAFA) conference in 2024, LCGC International sat down with Stefan van Leuwen of Wageningen Food Safety Research to discuss his research, which addresses emerging challenges in circular food production, focusing on the risks posed by pollutants when waste and by-products are repurposed in food systems.
Analyzing New Drug Modalities: An ISC 2024 Interview with Kelly Zhang
January 10th 2025At ISC 2024 in Liverpool, United Kingdom, LCGC International interviewed Kelly Zhang of Genentech about her work analyzing new drug modalities, such as mRNA, oligonucleotides, peptides, and cell and gene therapies.
USP CEO Discusses Quality and Partnership in Pharma
December 11th 2024Ronald Piervincenzi, chief executive officer of the United States Pharmacoepia, focused on how collaboration and component quality can improve worldwide pharmaceutical production standards during a lecture at the Eastern Analytical Symposium (EAS) last month.
